Literature DB >> 19118315

Reports of esophageal cancer with oral bisphosphonate use.

Diane K Wysowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19118315     DOI: 10.1056/NEJMc0808738

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  59 in total

1.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

2.  Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients.

Authors:  J M Neuner; T W Yen; R A Sparapani; P W Laud; A B Nattinger
Journal:  Osteoporos Int       Date:  2010-12-18       Impact factor: 4.507

3.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

4.  Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report.

Authors:  Ana Luiza Andrade Aragão; Ivani Novato Silva
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-21

Review 5.  Adverse effects of bisphosphonates: implications for osteoporosis management.

Authors:  Kurt A Kennel; Matthew T Drake
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

6.  Esophageal stricture associated with alendronate use.

Authors:  Asit K Paul; Mysore Seetharaman
Journal:  CMAJ       Date:  2011-02-22       Impact factor: 8.262

7.  Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010.

Authors:  Stephen K Liu; Jeffrey C Munson; John-Erik Bell; Rebecca L Zaha; John N Mecchella; Anna N A Tosteson; Nancy E Morden
Journal:  J Am Geriatr Soc       Date:  2013-10-28       Impact factor: 5.562

8.  Bisphosphonates for the treatment of osteoporosis: insights for clinicians.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

Review 9.  Management of osteoporosis in the aging male: focus on zoledronic acid.

Authors:  Paul K Piper; Ugis Gruntmanis
Journal:  Clin Interv Aging       Date:  2009-06-29       Impact factor: 4.458

Review 10.  Progress in osteoporosis and fracture prevention: focus on postmenopausal women.

Authors:  Kenneth G Saag; Piet Geusens
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.